Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Mounjaro is administered as a once-weekly subcutaneous injection and is typically prescribed when other diabetes medications have not achieved adequate blood glucose control
Any weight-related changes require consistent use for at least 8 to 12 weeks, combined with appropriate diet and exercise, which mirrors the patience required when starting GLP-1 medications and waiting for results to materialize
Kokkorakis M, Chakhtoura M, Rhayem C, et al
What Is GHK-Cu and Why Does It Matter
Chronic Weight Management Although Mounjaro is specifically branded for diabetes, its active ingredient, tirzepatide, is also the foundation of Zepbound, which is FDA-approved for chronic weight management
US$ 25.25
US$ 26.22
US$ 29.54
US$ 26.22
